Long COVID is the patient-coined term for the disease entity whereby persistent symptoms
ensue in a significant proportion of those who have had COVID-19, whether asymptomatic …

Long COVID is a public health emergency affecting millions of people worldwide,
characterized by heterogenous symptoms across multiple organs systems. Here, we discuss …

Background As defined by the WHO, the term post-COVID syndrome (PCS) embraces a
group of symptoms that can occur following the acute phase of a SARS-CoV-2 infection and …

The increasing number of coronavirus disease 2019 (COVID-19) infections have highlighted
the long-term consequences of severe acute respiratory syndrome coronavirus 2 (SARS …

Interferon‐induced transmembrane protein 3 (IFITM3) is an antiviral protein that alters cell
membranes to block fusion of viruses. Conflicting reports identified opposing effects of …

Since the very beginning of the coronavirus disease 2019 (COVID-19) pandemic in early
2020, it was evident that patients with cardiovascular disease (CVD) were at an increased …

COVID-19 is an independent risk factor for cardiovascular disease. COVID-19 vaccination
may prevent this, but in some cases, COVID-19 vaccination may cause myocarditis or …

A significant proportion of COVID‐19 patients experience debilitating symptoms for months
after the acute infection. According to recent estimates, approximately 1 out of 10 COVID‐19 …

Abstract Until January 2023, Brazil recorded 37 million COVID-19 cases despite the
decrease in mortality due to mass vaccination efforts against COVID-19. The infection …

Background Mechanisms underlying persistent cardiopulmonary symptoms after severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (postacute sequelae of …